ペプチド合成市場：試薬（樹脂、アミノ酸、色素）、装置（ペプチド合成機、クロマトグラフィー、凍結乾燥機）、技術（固相、溶液相、ハイブリッド）、サービス、エンドユーザー（製薬、バイオテクノロジー、CRO）、地域別 - 2028年までの世界予測

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028

世界のペプチド合成市場規模は、2023年の6億100万ドルから2028年には8億5900万ドルに達すると予測され、予測期間中の年平均成長率は7.4%である。ペプチド合成分野での進歩、ペプチド合成に使用される試薬の需要増... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年7月11日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	248	279	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界のペプチド合成市場規模は、2023年の6億100万ドルから2028年には8億5900万ドルに達すると予測され、予測期間中の年平均成長率は7.4%である。ペプチド合成分野での進歩、ペプチド合成に使用される試薬の需要増加などの要因が、ペプチド合成製品＆サービスの成長に好影響をもたらし、着実な成長が期待される。
"予測期間中、ペプチド合成市場の製品＆サービス別成長率は試薬セグメントが最も高い"
2022年、試薬セグメントが最も高い成長率を占めた。ペプチド合成試薬市場はさらに、樹脂、アミノ酸、カップリング試薬、染料・蛍光標識試薬、その他の試薬（保護試薬、リンカー、緩衝液、溶媒、溶液など）に区分される。大量の試薬が必要とされること、治療薬、ドラッグデザイン、遺伝子合成におけるペプチドの用途が拡大していることは、このセグメントの成長を予測する要因の一部である。
"アジア太平洋地域はより速いペースで成長する可能性が高い"
ペプチド合成市場は、北米、欧州、アジア太平洋、中南米、中東・アフリカに分けられる。2022年には、北米がペプチド合成市場で圧倒的なシェアを占めた。同地域の優位性は、同地域の大手企業の存在や、新たな標的療法開発のための継続的な研究活動など、さまざまな要因によるものである。アジア太平洋地域は、個別化治療に対する意識の高まり、同地域におけるジェネリック医薬品に対する政府のイニシアチブの高まり、ペプチド合成市場における新規参入企業の出現などの様々な要因により、より速いペースで成長する可能性が高い。
本レポートのために実施した一次インタビューは以下のように分類できる：

- 回答者別供給側70％、需要側30
- 回答者の役職別（供給側）マネージャー - 45%、CXOおよびディレクター - 30%、エグゼクティブ - 25
- 地域別北米：40％、欧州：25％、アジア太平洋地域：20％、中南米：10％、中東・アフリカ：5
レポート掲載企業リスト
- Bachem Holding AG (スイス)
- サーモフィッシャーサイエンティフィック（米国）
- Merck KGaA (ドイツ)
- GenScript Biotech Corporation (中国)
- 株式会社カネカ（日本）
- ビオテージAB（スウェーデン）
- シンジェン・インターナショナル社（インド(インド）
- メサ・ラボラトリーズ・インク（米国）
- CEMコーポレーション（米国）
- プロテオジェニックス（フランス）
- バイオシンセシス社（米国）
- ダルトンファーマサービス（カナダ）
- AAPPTec（米国）
- ビビタイド（米）
- エニジェン（韓国韓国
- CSBio（米国）
- アドバンスト・ケムテック（米）
- ルクセンブルグ・バイオ・テクノロジーズ(イスラエル）
- JPT Peptide Technologies GmbH（ドイツ）
- アンビオファーム社（米国）
- オーリジェン・ファーマシューティカル・サービス・リミテッド（インド(インド）
- コーデン・ファーマ・インターナショナル（ドイツ）
- ケムペップ・インク（米国）
- CPC Scientific Inc.
- Purolite Pvt Ltd.米国
調査範囲
この調査レポートは、ペプチド合成市場の詳細な状況を掲載しています。製品、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの企業プロフィールや最近の動向、主要な市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、ペプチド合成市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置付け、適切な市場参入戦略を立てるのに役立ちます。本レポートは、関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。
本レポートは、以下のポイントに関する洞察を提供します：
- 主な促進要因（医薬品におけるペプチド使用の増加、研究活動の増加と研究開発資金の確保、高度な自動ペプチド合成機の開発）、阻害要因（治療用ペプチドに関する統一された規制の欠如、機器の高コスト）、機会（アジア太平洋地域の新興市場、個別化医薬品の開発）、課題（ペプチド医薬品の投与経路に関連する問題、ペプチドの化学合成が環境に与える影響への対応）に関する分析。
- 製品とサービスの開発／革新：新しく発売された製品に関する詳細な洞察、ペプチド合成市場の技術評価。
- 市場開発：有利な市場に関する包括的な情報 - 当レポートでは、様々な地域のペプチド合成市場を分析しています。
- 市場の多様化：ペプチド合成市場における新製品＆サービス、未開拓の地域、最近の開発、投資に関する詳細な情報。
- 競合評価：GenScript Biotech Corporation（中国）、Thermo Fisher Scientific, Inc.（米国）、Bachem Holding AG（スイス）、Kaneka Corporation（米国）、Inc.（ドイツ）、Merck KGaA（ドイツ）など、ペプチド合成市場における主要企業の市場シェア、成長戦略、製品・サービス内容を詳細に評価。

ページTOPに戻る

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 34
1.3 MARKET SCOPE 35
1.3.1 MARKETS COVERED 35
1.3.2 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 36
1.5 LIMITATIONS 36
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 37
1.7.1 RECESSION IMPACT 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.2 PRIMARY DATA 40
FIGURE 2 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES 40
2.2 MARKET SIZE ESTIMATION 41
FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 41
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 42
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022 42
2.2.1 INSIGHTS FROM PRIMARIES 44
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 44
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER) 44
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 44
2.3 GROWTH RATE ASSUMPTIONS 45
FIGURE 8 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS, 2023–2028 46
FIGURE 9 PEPTIDE SYNTHESIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 46
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 10 DATA TRIANGULATION METHODOLOGY 47
2.5 STUDY ASSUMPTIONS 48
2.6 RISK ANALYSIS 48
2.7 IMPACT OF ECONOMIC RECESSION ON PEPTIDE SYNTHESIS MARKET 48
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 49
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 49
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 49
3 EXECUTIVE SUMMARY 50
FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 12 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 51
FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 51
FIGURE 14 PEPTIDE SYNTHESIS MARKET: GEOGRAPHICAL SNAPSHOT 52
4 PREMIUM INSIGHTS 53
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW 53
FIGURE 15 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND GROWING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH 53
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 54
FIGURE 16 REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2022 54
4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2022) 54
FIGURE 17 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 54
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 55
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE MARKET IN 2028 55
4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 20 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS 58
5.2.1 DRIVERS 58
5.2.1.1 Increasing use of peptides in pharmaceutical drugs 58
TABLE 5 PEPTIDE-BASED DRUGS APPROVED BY FOOD AND DRUG ADMINISTRATION 59
TABLE 6 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19 60
5.2.1.2 Increase in research activities and availability of funding for R&D 61
FIGURE 21 RISE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 61
5.2.1.3 Development of advanced automated peptide synthesizers 62
5.2.2 RESTRAINTS 63
5.2.2.1 Lack of unified set of regulations for therapeutic peptides 63
5.2.2.2 High cost of instruments 63
5.2.3 OPPORTUNITIES 64
5.2.3.1 Emerging markets in Asia Pacific region 64
5.2.3.2 Development of personalized medicines 64
5.2.4 CHALLENGES 65
5.2.4.1 Issues associated with route of administration of peptide drugs 65
5.2.4.2 Addressing environmental impact of chemical synthesis of peptides 65
5.3 RANGES/SCENARIOS 66
FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PEPTIDE SYNTHESIS MARKET 66
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.5 VALUE CHAIN ANALYSIS 67
FIGURE 23 VALUE CHAIN ANALYSIS OF PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE 67
5.6 TECHNOLOGY ANALYSIS 68
TABLE 7 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES 68
5.7 PATENT ANALYSIS 69
FIGURE 24 PATENT APPLICATIONS FOR PEPTIDE SYNTHESIS MARKET, JUNE 2013–JUNE 2023 69
TABLE 8 INDICATIVE LIST OF PATENTS IN PEPTIDE SYNTHESIS MARKET 70
5.8 ECOSYSTEM ANALYSIS OF PEPTIDE SYNTHESIS MARKET 72
TABLE 9 SUPPLY CHAIN ECOSYSTEM 72
5.9 PORTER’S FIVE FORCES ANALYSIS 74
TABLE 10 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS 74
5.9.1 THREAT OF NEW ENTRANTS 74
5.9.2 THREAT OF SUBSTITUTES 74
5.9.3 BARGAINING POWER OF SUPPLIERS 74
5.9.4 BARGAINING POWER OF BUYERS 75
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.10 REGULATORY ANALYSIS 75
5.10.1 REGULATIONS FOR PEPTIDE-BASED DRUGS 75
5.10.2 REGULATIONS FOR PEPTIDE SYNTHESIS PRODUCTS 75
5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.11 KEY CONFERENCES AND EVENTS IN 2023 79
TABLE 14 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023 79
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 79
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS 79
5.12.2 BUYING CRITERIA 80
FIGURE 26 KEY BUYING CRITERIA FOR END USERS 80
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE 81
6.1 INTRODUCTION 82
TABLE 15 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 82
6.2 REAGENTS 82
TABLE 16 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
TABLE 17 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 18 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 19 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 20 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 21 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.2.1 RESINS 85
6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost market 85
TABLE 22 PEPTIDE SYNTHESIS MARKET FOR RESINS, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 23 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 24 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 25 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 26 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.2.2 AMINO ACIDS 87
6.2.2.1 Amino acids play crucial role in synthesis of peptides 87
TABLE 27 PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 28 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 29 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 30 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 31 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.2.3 COUPLING REAGENTS 89
6.2.3.1 Vital role of coupling reagents in peptide bond formation to boost market 89
TABLE 32 PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 33 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 34 EUROPE: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 35 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 36 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.2.4 DYES & FLUORESCENT LABELING REAGENTS 92
6.2.4.1 Fluorescent labeling reagents play crucial role in understanding success rate of peptide synthesis reactions 92
TABLE 37 PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 38 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 39 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 40 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 41 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.2.5 OTHER REAGENTS 95
TABLE 42 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 43 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 44 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 45 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 46 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 97
6.3 EQUIPMENT 97
TABLE 47 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 48 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 49 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 50 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 51 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 52 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.3.1 PEPTIDE SYNTHESIZERS 100
6.3.1.1 Rising automation in peptide synthesizers to drive market growth 100
TABLE 53 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN MARKET 101
TABLE 54 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 55 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 56 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 57 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 58 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.3.2 CHROMATOGRAPHY EQUIPMENT 103
6.3.2.1 Reverse-phase HPLC used for purification of synthetic peptides to promote market growth 103
TABLE 59 PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 60 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 61 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 62 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 63 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.3 LYOPHILIZERS 106
6.3.3.1 Lyophilization to enable longer shelf life and easy transportation of peptides 106
TABLE 64 PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 65 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 66 EUROPE: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 67 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 68 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 108
6.4 SERVICES 108
6.4.1 RISE IN RESEARCH ACTIVITIES IN PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS TO DRIVE MARKET 108
TABLE 69 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 70 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 71 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 72 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 73 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY 111
7.1 INTRODUCTION 112
TABLE 74 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 112
7.2 SOLID-PHASE PEPTIDE SYNTHESIS 112
7.2.1 EASE OF USE OF SOLID-PHASE PEPTIDE SYNTHESIS TECHNOLOGY TO DRIVE GROWTH 112
TABLE 75 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 76 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 77 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 78 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 79 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS 115
7.3.1 ABILITY TO PRODUCE LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES COST-EFFECTIVELY TO DRIVE GROWTH 115
TABLE 80 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 81 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 82 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 83 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 84 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
7.4 HYBRID & RECOMBINANT TECHNOLOGY 118
7.4.1 PRODUCTION OF PEPTIDES WITH HIGH COMPLEXITY TO BOOST MARKET 118
TABLE 85 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 86 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 87 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 88 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 89 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121

8 PEPTIDE SYNTHESIS MARKET, BY END USER 122
8.1 INTRODUCTION 123
TABLE 90 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 123
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 123
8.2.1 USE OF PEPTIDES IN DRUG DEVELOPMENT APPLICATIONS TO DRIVE GROWTH 123
TABLE 91 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 92 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 93 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 94 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 95 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 126
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS AND CROS) 126
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO DRIVE GROWTH 126
TABLE 96 PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 97 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 98 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 99 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 100 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 129
8.4 ACADEMIC & RESEARCH INSTITUTES 129
8.4.1 INCREASE IN FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO BOOST MARKET GROWTH 129
TABLE 101 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 103 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 104 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 105 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 132

9 PEPTIDE SYNTHESIS MARKET, BY REGION 133
9.1 INTRODUCTION 134
TABLE 106 PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
9.2 NORTH AMERICA 134
FIGURE 27 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT 135
TABLE 107 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 108 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 136
TABLE 109 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 110 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 111 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 112 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 137
9.2.1 US 138
9.2.1.1 US to dominate North American peptide synthesis market during forecast period 138
TABLE 113 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 138
TABLE 114 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 115 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 116 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139
TABLE 117 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 140
9.2.2 CANADA 140
9.2.2.1 Availability of research funding in Canada to drive market growth 140
TABLE 118 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 141
TABLE 119 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 120 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 121 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 142
TABLE 122 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 142
9.3 EUROPE 142
TABLE 123 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 124 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 143
TABLE 125 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 126 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 127 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 144
TABLE 128 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 145
9.3.1 GERMANY 145
9.3.1.1 Government initiatives and rise in funding for peptide synthesis to propel growth 145
TABLE 129 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 146
TABLE 130 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 131 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 132 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 147
TABLE 133 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION) 147
9.3.2 UK 148
9.3.2.1 Growth in life science research to drive market growth 148
TABLE 134 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 148
TABLE 135 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 136 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 137 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 149
TABLE 138 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 150
9.3.3 FRANCE 150
9.3.3.1 Government funding for proteomics and genomics research to propel market growth 150
TABLE 139 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 151
TABLE 140 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 141 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 142 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 143 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 152
9.3.4 ITALY 152
9.3.4.1 Increase in life science research to boost market growth in Italy 152
TABLE 144 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 153
TABLE 145 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 146 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 147 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 148 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION) 154
9.3.5 SPAIN 155
9.3.5.1 Rising focus on research and innovation to support market growth 155
TABLE 149 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 156
TABLE 150 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 151 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 152 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 157
TABLE 153 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION) 157
9.3.6 REST OF EUROPE 157
TABLE 154 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 158
TABLE 155 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 156 REST OF EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 157 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 159
TABLE 158 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 159
9.4 ASIA PACIFIC 160
FIGURE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT 161
TABLE 159 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 160 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 162
TABLE 161 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 162 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 163 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 164
TABLE 164 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 164
9.4.1 CHINA 164
9.4.1.1 China to register highest growth rate due to increase in investments in R&D 164
TABLE 165 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 165
TABLE 166 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 167 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 168 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 166
TABLE 169 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 166
9.4.2 JAPAN 167
9.4.2.1 Rise in collaborations between companies in Japan to propel market growth 167
TABLE 170 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 167
TABLE 171 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 172 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 173 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 168
TABLE 174 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 169
9.4.3 INDIA 169
9.4.3.1 Government support for scientific research to drive market growth 169
TABLE 175 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 170
TABLE 176 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 177 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 178 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 179 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 171
9.4.4 SOUTH KOREA 171
9.4.4.1 Growing research efforts in biopharmaceutical sector to boost market growth 171
TABLE 180 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 181 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 182 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 183 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 173
TABLE 184 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 173
9.5 REST OF ASIA PACIFIC 173
TABLE 185 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 174
TABLE 186 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 187 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 188 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 175
TABLE 189 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 175
9.6 LATIN AMERICA 176
TABLE 190 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 191 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 176
TABLE 192 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 193 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 194 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 178
TABLE 195 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 178
9.6.1 BRAZIL 178
9.6.1.1 Rising government investments in research to propel market growth 178
TABLE 196 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 197 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 198 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 199 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 180
TABLE 200 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 180
9.6.2 MEXICO 180
9.6.2.1 Synthetic biology research advancements to drive market growth 180
TABLE 201 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 202 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 203 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 204 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 182
TABLE 205 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 182
9.6.3 REST OF LATIN AMERICA 182
TABLE 206 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 183
TABLE 207 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 208 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 209 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 184
TABLE 210 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 184
9.6.4 MIDDLE EAST & AFRICA 184
9.6.4.1 Growing pharmaceutical & biotechnology industries and increasing R&D activities to drive market growth 184
TABLE 211 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 185
TABLE 212 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 213 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 214 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 186
TABLE 215 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 186
10 COMPETITIVE LANDSCAPE 187
10.1 INTRODUCTION 187
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 188
FIGURE 29 PEPTIDE SYNTHESIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 188
10.3 REVENUE SHARE ANALYSIS 189
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 189
10.4 MARKET SHARE ANALYSIS 189
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 190
TABLE 216 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION 190
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 191
FIGURE 32 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 192
10.5.1 STARS 192
10.5.2 EMERGING LEADERS 192
10.5.3 PERVASIVE PLAYERS 193
10.5.4 PARTICIPANTS 193
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 193
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 193
TABLE 217 PEPTIDE SYNTHESIS MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 193
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 194
TABLE 218 PEPTIDE SYNTHESIS MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 194
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 196
FIGURE 33 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 196
10.7.1 PROGRESSIVE COMPANIES 197
10.7.2 STARTING BLOCKS 197
10.7.3 RESPONSIVE COMPANIES 197
10.7.4 DYNAMIC COMPANIES 197
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 197
TABLE 219 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 197
TABLE 220 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 198
10.9 COMPETITIVE SCENARIO AND TRENDS 199
10.9.1 PRODUCT LAUNCHES 199
TABLE 221 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 199
10.9.2 DEALS 200
TABLE 222 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2020–JUNE 2023 200
10.9.3 OTHER DEVELOPMENTS 200
TABLE 223 PEPTIDE SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023 200

ページTOPに戻る

Table of Contents

Summary

The global peptide synthesis market size is projected to reach USD 859 million by 2028 from 601 million in 2023, at a CAGR of 7.4 % during the forecast period. Factors such advancement in the field of peptide synthesis, and increased demand for reagents used in peptide synthesis is expected to experience steady growth leading to positive impact on the growth of peptide synthesis products & services.
“The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period”
In 2022, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, expanding applications of peptides in therapeutics, drug design, and gene synthesis are some of the factors anticipated to project the growth of the segment.
“Asia Pacific region is likely to grow at a faster pace.”
The peptide synthesis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the peptide synthesis market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the peptide synthesis market.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
• Bachem Holding AG (Switzerland)
• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• GenScript Biotech Corporation (China)
• Kaneka Corporation (Japan)
• Biotage AB (Sweden)
• Syngene International Ltd. (India)
• Mesa Laboratories Inc. (US)
• CEM Corporation (US)
• ProteoGenix (France)
• Bio-Synthesis Inc. (US)
• Dalton Pharma Services (Canada)
• AAPPTec (US)
• vivitide (US)
• AnyGen Co., Ltd. (South Korea)
• CSBio (US)
• Advanced Chemtech (US)
• Luxembourg Bio Technologies Ltd. (Israel)
• JPT Peptide Technologies GmbH (Germany)
• AmbioPharm Inc. (US)
• Aurigene Pharmaceutical Services Ltd. (India)
• Corden Pharma International (Germany)
• ChemPep Inc. (US)
• CPC Scientific Inc. (US)
• Purolite Pvt Ltd. (US)
Research Coverage:
This report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers), restraints (Lack of a unified set of regulations for therapeutic peptides, High cost of instruments), opportunities (Emerging markets in the Asia Pacific region, Development of personalized medicines), and challenges (Issues associated with the route of administration of peptide drugs, Addressing environmental impact of chemical synthesis of peptides.)
• Product & Service Development/Innovation: Detailed insights on newly launched products, and technological assessment of the peptide synthesis market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the peptide synthesis market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the peptide synthesis market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc.and Merck KGaA (Germany) and among others in the peptide synthesis market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（peptide）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（peptide）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?